Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by conjugated linoleic acid in murine macrophages

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 67, Issue 6, 2002, Pages 435-443

  Iwakiri, Y ^a   Sampson, D A ^a   Allen, Kenneth ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; BACTERIAL POLYSACCHARIDE; CYCLOOXYGENASE 2; ENDOTOXIN; LINOLEIC ACID; LIPID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; MESSENGER RNA; NOS2 PROTEIN, MOUSE; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFECT; DRUG MECHANISM; ENZYME INDUCTION; ENZYME INHIBITION; GENETIC TRANSCRIPTION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MACROPHAGE; METABOLISM;

BACTERIA (MICROORGANISMS); MURINAE;

ANIMALS; CELL LINE; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; ISOENZYMES; LINOLEIC ACID; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER;

EID: 0036893748     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2002.0454     Document Type: Article

References (63)

1. Chin S. F., Liu W., Storkson J. M., Ha Y. L., Pariza M. W. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J Food Compos Anal 1992; 5: 185-197.
2. Pariza M. W., Loretz L. J., Storkson J. M., Holland N.C. Mutagens and modulator of mutagenesis in fried ground beef. Cancer Res 1983; 43 (Suppl): 2444s-2446s.
3. Parodi P. W. Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat. J Dairy Sci 1999; 82: 1339-1349.
4. Ip C., Banni S, Angioni E., Carta G., McGinley J., Thompson H. J., Barbano D., Bauman D. Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J Nutr 1999; 129: 2135-2142.
5. Ip M. M., Masso-Welch P. A., Shoemaker S. F., Shea-Eaton W. K., Ip C. Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res 1999; 250: 22-34.
6. Thompson H., Zhu Z., Banni S., Darcy K., Loftus T., Ip C. Morphological and biochemical status of the mammary gland as influenced by conjugated linoleic acid: Implication for a reduction in mammary cancer risk. Cancer Res 1997; 57: 5067-5072.
7. Belury M. A., Nickel K. P., Bird C. E., Wu Y. Dietary conjugated linoleic acid modulation of phorbol ester skin tumor promotion. Nutr Cancer 1996; 26: 149-157.
8. Liu K. L., Belury M. A. Conjugated linoleic acid modulation of phorbol ester-induced events in murine keratinocytes. Lipids 1997; 32: 725-730.
9. Schut H. A., Cummings D. A., Smale M. H., Josyula S., Friesen M. D. DNA adducts of heterocyclic amines: Formation, removal and inhibition by dietary components. Mutat Res 1997; 376: 185-194.
10. Liew C., Schut H. A., Chin S. F., Pariza M. W., Dashwood R. H. Protection of conjugated linoleic acids against 2-amino-3-methylimidazo[4, 5-f]quinoline-induced colon carcinogenesis in the F344 rat: A study of inhibitory mechanisms. Carcinogenesis 1995; 16: 3037-3043.
11. Xu M., Dashwood R. H. Chemoprevention studies of heterocyclic amine-induced colon carcinogenesis. Cancer Lett 1999; 143: 179-183.
12. Banni S., Angioni E., Casu V., Melis M. P., Carta G., Corongiu F. P., Thompson H., Ip C. Decrease in linoleic acid metabolites as a potential mechanism in cancer risk reduction by conjugated linoleic acid. Carcinogenesis 1999; 20: 1019-1024.
13. Williams C. S., DuBois R. Prostaglandin Endoperoxide synthase: Why two isoforms? Am J Physiol 1996; 270: G393-G400.
14. von Knethen A., Callsen D., Brune B. Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression. J Immunol 1999; 163: 2858-2866.
15. Jones M. K., Wang H., Peskar B. M., Levin E., Itani R. M., Sarfeh I. J., Tarnawski A. S. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999; 5: 1418-1423.
16. Cesano A., Visonneau S., Scimeca J. A., Kritchevsky D., Santoli D. Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. Anticancer Res 1998; 18: 1429-1434.
17. Rees R. C., Parry H. Macrophages in tumor immunity. In: Lewis C. E., McGee J. O., eds. The Macrophage: The Natural Immune System. New York: Oxford University Press, 1992; 315-357.
18. Ziche M., Morbidelli L., Choudhuri R., Zhang H. T., Donnini S., Granger H. J., Bicknell R. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99: 2625-2634.
19. Jadeski L. C., Lala P. K. Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Am J Pathol 1999; 155: 1381-1390.
20. Adams M. D., Kerlavage A. R., Fleischmann R. D., et al. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of sDNA sequence. Nature 1995; 377: 3-174.
21. Oberbaumer I. New pUC-derived expression vectors for rapid construction of cDNA libraries. Gene 1986; 49: 81-91.
22. Oberbaumer I. Retroposons do jump: A B2 dement recently ingegrated in an 18S rDNA gene. Nucleic Acids Res 1992; 20: 671-677.
23. Brown T. Preparation and analysis of RNA. In: Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Siedmen J. A., Smith J. T., Struhl K., eds. Current Protocols in Molecular Biology New York: Wiley, 1993; 4.9.1-4.9.8.
24. Steinberg L. Y., Mauldin R. E., Mathias M. M. The effect of dietary lipids on clotting times and rat serum and urine prostaglandin. Prog Lipid Res 1982; 20: 485-489.
25. Morin C. L., Allen K. G. D., Mathias M. M. Thromboxane production in copper-deficient and marginal platelets: Influence of superoxide dismutase and lipid hydroperoxides. Proc Soc Exp Biol Med 1993; 202: 167-173.
26. Green L. C., Wagner D., Glogowski P. L., Skipper J. S., Wishnok J. S., Tannenbaum S. R. Analysis of nitrate, nitrite, and (15N) in biological fluids. Anal Biochem 1982; 126: 131-138.
27. LaBarca C., Paigen K. A simple, rapid and sensitive DNA assay procedure. Anal Biochem 1980; 102: 344-352.
28. Liu K.-L., Belury M. A. Conjugated linoleic acid reduces arachidonic acid content and PGE2 synthesis in murine keratinocytes. Cancer Lett 1998; 127: 15-22.
29. Sugano M., Tsujita A., Yamasaki M., Noguchi M., Yamada K. Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats. Lipids 1998; 33: 521-527.
30. Turek J. J., Li Y., Schoenlein I. A., Allen K. G. D., Watkins B. A. Modulation of macrophage cytokine production by conjugated linoleic acids is influenced by the dietary n-6:n-3 fatty acid ratio. J Nutr Biochem 1998; 9: 258-266.
31. Earnest D. V., Hixson L. J., Alberts D. S. Piroxicam and other cyclooxygenase inhibitors: Potential for cancer chemoprevention. J Cell Biochem 1992; 161: 156-166.
32. Moya-Camarena S. Y., Van den Heuvel J. P., Belury M. A. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats. Biochim Biophys Acta 1999; 1436: 331-342.
33. Moya-Camarena S. Y., Van den Heuvel J. P., Blanchard S. G., Leesnitzer L. A., Belury M. A. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J Lipid Res 1999; 40: 1426-1433.
34. Ricote M., Li A. C., Willson T. M., Kelly C. J., Glass C. K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391: 79-82.
35. Brand K., Page S., Rogler G., Bartsch A., Brandl R., Knuechel R., Page M., Kaltschmidt C., Baeuerle P. A., Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J CIin Invest 1996; 97: 1715-1722.
36. Bourcier T., Sukhova G., Libby P. The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem 1997; 272: 15, 817-15, 824.
37. Chinetti G., Griglio S., Antonucci M., Torra I. P., Delerive P., Majd Z., Fruchart J. C., Chapman J., Najib J., Staels B. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 1998; 273: 25, 573-25, 580.
38. Staels B., Koenig W., Habib A., Merval R., Lebret M., Torra I. P., Delerive P., Fadel A., Chinetti G., Fruchart J. C., Najib J., Maclouf J., Tedgui A. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 1998; 393: 790-793.
39. Hwang D., Jang B. C., Yu G., Boudreau M. Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: Mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages. Biochem Pharmacol 1997; 54: 87-96.
40. Chen C. C., Chin K. T., Sun Y. T., Chen W. C. Role of the cyclic AMP-protein kinase A pathway in lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages. Involvement of cyclooxygenase-2. J Biol Chem 1999; 274: 31, 559-31, 564.
41. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347: 645-650.
42. Donald R., Ballard D. W., Hawiger J. Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators. J Biol Chem 1995; 270: 9-12.
43. Lin Y. Z., Yao S. Y., Veach R. A., Torgerson T. R., Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 1995; 270: 14, 255-14, 258.
44. Henkel T., Machleidt T., Alkalay I., Kronke M., Ben-Neriah Y., Baeuerle P. A. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 1993; 365: 182-185.
45. Lo C. J., Cryer H. G., Fu M., Lo F. R. Regulation of macrophage eicosanoid generation is dependent on nuclear factor kappaB. J Trauma 1998; 45: 19-23.
46. Xie Q. W., Kashiwabara Y., Nathan C. Role of transcription factor NE-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705-4708.
47. Colville-Nash P. R., Qureshi S. S., Willis D., Willoughby D. A. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: Correlation with induction of heine oxygenase 1. J Immunol 1998; 161: 978-984.
48. Meade E. A., McIntyre T. M., Zimmerman G. A, Prescott S. M. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J Biol Chem 1999; 274: 8328-8334.
49. Belury M. A., Kempa-Steczko A. Conjugated linoleic acid modulates hepatic lipid composition in mice. Lipids 1997; 32: 199-204.
50. Delerive P., De Bosscher K., Besnard S., Vanden Berghe W., Peters J. M., Gonzalez F. J., Fruchart J. C., Tedgui A., Haegeman G., Staels B. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 1999; 274: 32, 048-32, 054.
51. Yu L. Free radical scavenging effect properties of conjugated linolenic acids. J Agric Food Chem 2001; 49: 3452-3456.
52. Janssen-Heininger Y. M., Poynter M. E., Baeuerle P. A. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med 2000; 28: 1317-1327.
53. Ohata T., Fukuda K., Takahashi M., Sugimura T., Wakabayashi K. Suppression of nitric oxide production in lipopolysaccharide-stimulated macrophage cells by omega 3 polyunsaturated fatty acids. Jpn J Cancer Res 1997; 88: 234-237.
54. Chapkin R. S., Somers S. D., Erickson K. L. Inability of murine peritoneal macrophages to convert linoleic acid into arachidonic acid. Evidence of chain elongation. J Immunol 1988; 140: 2350-2355.
55. Murakami K., Ide T., Suzuki M., Mochizuki T., Kadowaki T. Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha. Biochem Biophys Res Commun 1999; 260: 609-613.
56. Lin Q., Ruuska S. E., Shaw N. S., Dong D., Noy N. Ligand selectivity of the peroxisome proliferator-activated receptor alpha. Biochemistry 1999; 38: 185-190.
57. Sessler A. M., Ntambi J. M. Polyunsaturated fatty acid regulation of gene expression. J Nutr 1998; 128: 923-926.
58. Gottlicher M., Widmark E., Li Q., Gustafsson J. A. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA 1992; 89: 4653-4657.
59. Ren B., Thelen A., Peters J. M., Gonzalez F. J., Jump D. B. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha. J Biol Chem 1997; 272: 26, 827-26, 832.
60. Mater M. K., Thelen A. P, Pan D. A., Jump D. B. Sterol response element-binding protein 1c (SREBP1c) is involved in the polyunsaturated fatty acid suppression of hepatic S14 gene transcription. J Biol Chem 1999; 274: 32, 725-32, 732.
61. Jump D. B., Thelen A., Mater M. Dietary polyunsaturated fatty acids and hepatic gene expression. Lipids 1999; 34: S209-S212.
62. Schonbeck U., Sukhova G. K., Graber P., Coulter S., Libby. P. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 1999; 155: 1281-1291.
63. Depre C., Havaux X., Renkin J., Vanoverschelde J. L., Wijns W. Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque. Cardiovasc Res 1999; 41: 465-472.